Guoli Li

InstitutionCapital medical university
AddressBeijing
China
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 5 Covid-19 publications, with a maximum of 2 publications in August 2020
    All Publications
    Bar chart showing 67 publications over 18 distinct years, with a maximum of 12 publications in 2017
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Han J, Zhang N, Chen D, Gong Y, Li G, Kong Y, Pu L, Chen C, Liu J, Wang Q, Zhang J, Zhao X, Du J, Han K, Song C, Wang L, Hua M, Hao Y, Song R, Song Y, Yu F, Yang S, Xiong H, Zhang W, Gao GF, Zhang F, Li A, Zeng H, Bi Y. Distinct durability of IgM/IgG antibody responses in COVID-19 patients with differing severity. Sci China Life Sci. 2022 01; 65(1):223-226. PMID: 34086155.
      Citations: 1     Fields:    Translation:Humans
    2. Li G, Su B, Fu P, Bai Y, Ding G, Li D, Wang J, Yang G, Chu B. NPC1-regulated dynamic of clathrin-coated pits is essential for viral entry. Sci China Life Sci. 2022 02; 65(2):341-361. PMID: 34047913.
      Citations: 1     Fields:    
    3. Kong Y, Wang Y, Wu X, Han J, Li G, Hua M, Han K, Zhang H, Li A, Zeng H. Storm of soluble immune checkpoints associated with disease severity of COVID-19. Signal Transduct Target Ther. 2020 09 07; 5(1):192. PMID: 32895366.
      Citations: 8     Translation:HumansCellsPHPublic Health
    4. Zhao X, Chen D, Szabla R, Zheng M, Li G, Du P, Zheng S, Li X, Song C, Li R, Guo JT, Junop M, Zeng H, Lin H. Broad and Differential Animal Angiotensin-Converting Enzyme 2 Receptor Usage by SARS-CoV-2. J Virol. 2020 08 31; 94(18). PMID: 32661139.
      Citations: 55     Fields:    Translation:HumansAnimalsCellsPHPublic Health
    5. Zhao X, Zheng S, Chen D, Zheng M, Li X, Li G, Lin H, Chang J, Zeng H, Guo JT. LY6E Restricts Entry of Human Coronaviruses, Including Currently Pandemic SARS-CoV-2. J Virol. 2020 08 31; 94(18). PMID: 32641482.
      Citations: 26     Fields:    Translation:HumansCellsPHPublic Health
    6. Chen D, Hou Z, Jiang D, Zheng M, Li G, Zhang Y, Li R, Lin H, Chang J, Zeng H, Guo JT, Zhao X. GILT restricts the cellular entry mediated by the envelope glycoproteins of SARS-CoV, Ebola virus and Lassa fever virus. Emerg Microbes Infect. 2019; 8(1):1511-1523. PMID: 31631785.
      Citations: 9     Fields:    Translation:HumansCells